| Literature DB >> 30175458 |
Eri Takenami1, ShinMin Iwamoto2, Noriko Shiraishi3, Akiko Kato2, Yuichi Watanabe2, Yoshifumi Yamada4, Satoru Yamada4, Naokata Ishii1.
Abstract
AIMS/Entities:
Keywords: Fast muscle fibers; Glycated hemoglobin; Resistance training
Mesh:
Substances:
Year: 2018 PMID: 30175458 PMCID: PMC6400238 DOI: 10.1111/jdi.12926
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Figure 1Schematic representation of the study protocol. CPK, blood creatine phosphokinase; HbA1c, glycated hemoglobin; LST, low‐intensity resistance training with slow movement and tonic force generation.
Baseline physical and clinical characteristics
| Acute study | Long‐term study | |
|---|---|---|
|
| 10 | 9 |
| Sex (men/women) | 5/5 | 5/4 |
| Age (years) | 68.2 ± 9.7 | 69.8 ± 8.8 |
| Height (cm) | 162.9 ± 6.7 | 163.2 ± 7.0 |
| Weight (kg) | 64.8 ± 8.2 | 65.0 ± 8.7 |
| Body mass index (kg/m2) | 24.4 ± 2.4 | 24.4 ± 2.6 |
| Retinopathy | ||
| None | 9 | 8 |
| Simple | 1 | 1 |
| Preproliferative | 0 | 0 |
| Proliferative | 0 | 0 |
| Albuminuria | ||
| Normo | 9 | 8 |
| Micro | 1 | 1 |
| Macro | 0 | 0 |
| Treatment | ||
| Untreated | 0 | 0 |
| Oral hypoglycemic agents | 9 | 8 |
| Insulin | 1 | 1 |
| Anticholesteremic agents | 5 | 4 |
| Antihypertensive agents | 3 | 3 |
Age, height, weight and body mass index are expressed as mean ± standard deviation. Other variables are shown as the number of participants.
Changes in participant characteristics
| Pre‐training | Post‐training |
| ES | |
|---|---|---|---|---|
| Changes in measures of body composition | ||||
| Bodyweight (kg) | 65.0 ± 8.7 | 64.1 ± 8.4 | 0.0499 | 0.10 |
| Body mass index (kg/m2) | 24.4 ± 2.6 | 24.1 ± 2.5 | 0.069 | 0.12 |
| Body fat mass (kg) | 21.2 ± 5.0 | 20.2 ± 5.0 | 0.012 | 0.20 |
| Body fat percentage (%) | 32.8 ± 6.8 | 31.5 ± 6.6 | 0.012 | 0.18 |
| Total LBM (kg) | 41.3 ± 6.7 | 41.4 ± 5.9 | 0.866 | 0.02 |
| LBM of lower limbs (kg) | 13.3 ± 2.3 | 13.3 ± 2.3 | 0.889 | 0.01 |
| LBM of trunk (kg) | 19.6 ± 2.9 | 20.0 ± 2.7 | 0.161 | 0.12 |
| Total LBM/bodyweight (%) | 63.6 ± 6.6 | 64.7 ± 6.5 | 0.012 | 0.18 |
| LBM of lower limbs/bodyweight (%) | 20.4 ± 1.9 | 20.7 ± 2.0 | 0.674 | 0.15 |
| LBM of trunk/bodyweight (%) | 30.3 ± 3.5 | 31.4 ± 4.1 | 0.017 | 0.27 |
| Muscle thickness of front portion of the thigh (mm) | 42.3 ± 6.0 | 44.3 ± 7.5 | 0.021 | 0.29 |
| Changes in glycemic control | ||||
| HbA1c (%) | 7.1 ± 0.5 | 6.8 ± 0.4 | 0.066 | 0.54 |
| Fasting plasma glucose (mg/dL) | 124.8 ± 16.5 | 129.6 ± 31.2 | 0.767 | 0.19 |
| Changes in muscle strength | ||||
| Isokinetic knee extension peak torque (N·m) | ||||
| 60°/s | 72.9 ± 32.1 | 80.4 ± 28.4 | 0.015 | 0.25 |
| 180°/s | 46.3 ± 17.7 | 52.7 ± 19.6 | 0.021 | 0.34 |
| Isokinetic knee flexion peak torque (N·m) | ||||
| 60°/s | 42.7 ± 20.7 | 50.9 ± 20.2 | 0.012 | 0.40 |
| 180°/s | 25.3 ± 12.4 | 36.2 ± 12.3 | 0.008 | 0.88 |
| Maximum leg press strength (kg) | 62.4 ± 19.9 | 101.2 ± 22.7 | 0.008 | 1.82 |
Values are expressed as mean ± standard deviation. ES, effect size; LBM, lean body mass; HbA1c, glycated hemoglobin.
Figure 2Changes in glycated hemoglobin (HbA1c) in the long‐term study. Dotted lines show the changes for each participant. The solid bold line shows the change in mean value for all (9) participants.
Figure 3Change in glycated hemoglobin (HbA1c) versus changes in isokinetic knee extension peak torque. (a) Isokinetic knee extension peak torque at 180°/s. (b) Isokinetic knee extension peak torque at 60°/s.